comparemela.com

Latest Breaking News On - சிங் தியோ - Page 33 : comparemela.com

Covaxin efficacy data has no effect on opposition states

Covaxin efficacy data has no effect on opposition states SECTIONS Share Synopsis A day after Hyderabad-based Bharat Biotech reported its interim data, the three states on Thursday said they would wait for a formal approval from the Drugs Controller General of India (DCGI) before using Covaxin for the immunisation drive. AFP The Opposition-ruled states of Punjab, Chhattisgarh and Kerala, which have refused to use Bharat Biotech s Covaxin, have not changed their stance even after the manufacturer released interim data showing 81% vaccine efficacy in phase 3 clinical trial. A day after Hyderabad-based Bharat Biotech reported its interim data, the three states on Thursday said they would wait for a formal approval from the Drugs Controller General of India (DCGI) before using Covaxin for the immunisation drive.

Is Bharat Biotech s Covaxin safe, now that it shows 81% efficacy? — Quartz India

Welcome To IANS Live - NATION - TS Singh Deo named Cong observer for Tripura tribal council polls

Congress appoints TS Singh Deo as party observer for upcoming Tripura Tribal Area District Council polls

Chhattisgarh Minister TS Singh Deo (File Photo) Congress appoints TS Singh Deo as party observer for upcoming Tripura Tribal Area District Council polls ANI | Updated: Mar 03, 2021 18:14 IST New Delhi [India], March 3 (ANI): Congress on Wednesday appointed Chhattisgarh MinisterTS Singh Deo as senior All India Congress Committee (AICC) observer for overseeing election campaign management and coordination in Tribal Areas Autonomous District Council election in Tripura. Congress President has appointed TS Singh Deo as senior AICC observer for overseeing Election Campaign Management and Coordination in the upcoming Tribal Areas Autonomous District Council (ADC) elections in Tripura with immediate effect, read a press statement from the AICC.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.